How is age-related macular degeneration diagnosed? Which patient is at risk of the disease? What are the treatment options? These, in short, are the questions to which some of the most authoritative have been asked to answerspecialists in ophthalmology, during the webinar recently held within the training course of Floretina 2021, on the topic ‘Neovascular Amd in real life’, chaired by Edoardo Midena, professor of Diseases of the visual apparatus and director of the School of Specialization in Ophthalmology of the University of Padua, and by Stanislao Rizzo, director of the Ophthalmology complex operating unit of the A. Gemelli Irccs University Hospital of Rome, organized with the unconditional contribution of Bayer.
Read Also
- Why some backers of student lending product welcome CFPB crackdown Sep 14, 2021
- Prince Harry : the exorbitant price of his new bodyguards, specialists of the stars Jun 4, 2020
- Kim Kardashian and Kanye West allegedly lead “separate lives” Dec 14, 2020
- The Community advances in the installation of 1,000 humidity probes in the surroundings of the Mar Menor Sep 21, 2021
- “No to the Green pass to the university”, the historian Alessandro Barbero also signs the appeal of the teachers Sep 6, 2021
- The restrictions in Archena reactivate the internal battle in the regional PP Jul 15, 2021
- Salma Hayek paid tribute to mature women on Instagram Sep 23, 2020